Norwegian screening program reduces breast cancer-related death rates
the ONA take:
A Norwegian breast cancer screening program has markedly reduced breast cancer mortality, according to an evaluation of the pilot project.
As part of the Norwegian Breast Cancer Screening Programme, all women aged 50 to 69 are invited to undergo a mammography screening every 2 years. When the program was launched in 1995, only women in four Norwegian counties were invited to participate, but in 2004, the project went national.
The evaluation showed that the screening program reduced breast cancer mortality by up to 20 to 30% in women aged 50 to 69 who have been followed up until age 79. The goal of the program was to reduce breast cancer-related death by 30%.
The researchers estimate that for every 100,000 women invited to participate in the program, approximately 377 cases of tumors or pre-malignant breast lesions will be identified. Of those, about 27 will avoid breast cancer-related death due to early diagnosis and treatment.
The downside of the program is that approximately 142 per 100,000 women will be overdiagnosed with breast cancer.
A Norwegian breast cancer screening program has markedly reduced breast cancer mortality.
Sign Up for Free e-newsletters
- Incidence of Post-traumatic Stress Disorder High Among Patients With Cancer
- Long-Term Night Shift Work Associated With Cancer Risk in Women
- Distress, Neuroticism Predict Long-term Emotional Distress After Cancer Diagnosis
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- FDA Grants Breakthrough Therapy Designation to Lenvatinib Plus Pembrolizumab for RCC
- Bacteria in Probiotics Carry Potential Risks for Immunocompromised Patients
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Breast Cancer Deaths Decrease Sharply Since 2000
- Identifying the Psychosocial Needs of Young Adults With Metastatic Cancer
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|